Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis - Poll - MDSpire

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • By

  • Shrila Banerjee

  • Abul Kalam Azad Mandal

  • June 11, 2026

  • 0 min

Share

Original Source(s)

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

  • by Shrila Banerjee, Abul Kalam Azad Mandal

  • June 11, 2026

Related Content

Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma

Latent transition analysis of resilience in breast cancer patients and its association with sense of meaning in life: a longitudinal follow - up study

Ultrasound-derived pelvic floor parameters and their association with functional impairment in gynecologic cancer survivors: a retrospective cohort study